Florida Senator Rick Scott (R) continues press for relocating generic drug production from foreign countries, such as India and China, to the U.S. during a hearing with the U.S. Senate Special Committee on Aging.
Scott, who is the chairman of the special committee, highlighted various U.S. companies that are successfully producing generic medications domestically, and he emphasized the critical role American manufacturing plays in ensuring drug safety, creating jobs, and strengthening America’s national security.
“When we manufacture here at home, we can control quality, strengthen oversight, and protect patients," Scott explained. "We also benefit from creating good-paying jobs and growing our economy. Today’s witnesses are proof that American manufacturing works. These companies show that it’s possible and profitable to make safe, affordable medicines in the U.S.”
The Florida Senator, while emphasizing the importance of shifting production to the U.S., also explained the shortcomings that come with producing generic drugs in the U.S.
Throughout the hearing, witnesses described how American manufacturers continue to face steep challenges when trying to rebuild the nation’s pharmaceutical industry.
Committee members highlighted these obstacles while also outlining a path forward, emphasizing the need to boost U.S. innovation, create a level playing field for domestic producers, and accelerate efforts to break away from America’s reliance on foreign-made generic medicines.
“It is UNACCEPTABLE that the most advanced country in the world can’t ensure a steady, safe supply of basic medicines for its own citizens,” Scott exclaimed. “Red tape at the FDA delays approvals and drives up cost – something I and many of my colleagues are interested in fixing. The federal government should lead by example. The VA, Medicare, and our military health programs should prioritize American-made medicines.”
The Senator previously held another hearing where he brought forth various health experts as witnesses, who agreed that not knowing the origin of the ingredients used in the drugs millions of Americans take daily, coupled with the lack of FDA oversight, poses a crucial threat to national security and public health.
